Cannabis Penny Stocks To Buy 2017 May 2026

Growth in Canadian medical sales and preparation for adult-use Partnership with Constellation Brands InMed Pharmaceuticals Research into cannabinoid-based therapies

: A unique feature of 2017 was the divergence between markets. While Canadian licensed producers (LPs) like Aphria and Village Farms flourished under a clear path to federal legalization, U.S.-based stocks remained largely stagnant due to federal prohibition and legal uncertainty. Notable Performers of 2017 Stock Name 2017 Performance (Approx.) Key Driver Aurora Cannabis (ACB) cannabis penny stocks to buy 2017

: A watershed moment occurred in October 2017 when beverage giant Constellation Brands bought a 9.9% stake in Canopy Growth for $245 million. This validated the industry to institutional investors and triggered massive rallies across other penny stocks like Aurora Cannabis , which surged as investors searched for the next major partner. Growth in Canadian medical sales and preparation for

: While large-cap players saw triple-digit gains, ultra-low-priced "sub-penny" stocks saw even more extreme volatility. For example, Sprout Tiny Homes Inc. (STHI) reportedly gained 7,150% during the year, while UMF Group Inc. (UMFG) rose 7,100% . This validated the industry to institutional investors and

While 2017 was a banner year, it was also highly speculative; subsequent years saw many of these same stocks lose significant value as the "hype" met the reality of post-legalization logistics.